Net Asset Value • Jan 26, 2015
Net Asset Value
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information
RNS Number : 9946C
Hutchison China Meditech Limited
26 January 2015
Hutchison China MediTech Limited ("Chi-Med")
(AIM: HCM)
Notice of Announcement of 2014 Final Results
London: Monday, 26 January 2015: Chi-Med will be announcing its final results for the year ended 31 December 2014 on Thursday, 26 February 2015. An analyst presentation will be held at 9:00 am on the same day at Citigate Dewe Rogerson, 3 London Wall Buildings, London, EC2M 5SY.
Ends
| Chi-Med Christian Hogg, CEO |
Telephone: +852 2121 8200 |
| Panmure Gordon (UK) Limited | Telephone: +44 20 7886 2500 |
| Richard Gray Andrew Potts |
|
| Citigate Dewe Rogerson Anthony Carlisle David Dible |
Telephone: +44 20 7638 9571 Mobile: +44 7973 611 888 Mobile: +44 7967 566 919 |
Chi-Med is a China-based healthcare group focused on researching, developing, manufacturing and selling pharmaceuticals and health-related consumer products. Its China Healthcare Division manufactures, markets and distributes prescription and over-the-counter pharmaceuticals in China. Its Drug R&D Division focuses on discovering and developing innovative therapeutics in oncology and autoimmune diseases. Its emerging Consumer Products Division focuses on organic and natural consumer products in Asia.
Chi-Med is majority owned by the multinational conglomerate Hutchison Whampoa Limited (SEHK:13). For more information, please visit: www.chi-med.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORKMGZMGFKGKZM
//<![CDATA[$.ajaxSetup({headers: {'__RequestVerificationToken':'jb_QM4qqJWN-Yf_Br-6LuQ4j_bWwJI7VCtRhNlRS3fQom0ORY5-k_Y3sFZUBvVHFlUvknrOlCy1NvqTQrIcXCL2gFT_i57JgswmTuBBktFM1:02ZtsiOMttcJ857e2AfAXrCsgsdEhjFXSs9m56IWe_rUT3jwi4dxdvOiKs9Ya9BdJlJymQyfWvZYnxOoCrGL6UXGw8pEwbbpN4zKtIxAEqY1'}});//]]>